Kanzo and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Kanzo (licorice), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Rabeprazole Sodium, and have High blood pressure.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Kanzo. It is created by eHealthMe based on reports of 352 people who have side effects when taking Kanzo from the FDA, and is updated regularly.

What is Kanzo?

Kanzo has active ingredients of licorice. eHealthMe is studying from 352 Kanzo users. Check the latest studies of Kanzo.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,524 drugs and 4,592 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 10, 2026

352 people reported to have side effects when taking Kanzo.
Among them, 16 people (4.55%) have Appetite - decreased.

Among these 16 people:

How long have people been on Kanzo when they have Appetite - decreased? *

What is the gender of people who have Appetite - decreased when taking Kanzo? *

female: 50 %
male: 50 %

What is the age of people who have Appetite - decreased when taking Kanzo? *

What are other drugs people take besides Kanzo? *

Lasix: 4 people, 25.00%
Rabeprazole Sodium: 4 people, 25.00%
Kanamycin: 3 people, 18.75%
Magnesium Oxide: 3 people, 18.75%
Pyridoxal Phosphate: 3 people, 18.75%
Zyvox: 2 people, 12.50%
Prednisolone: 2 people, 12.50%
Cinacalcet Hydrochloride: 2 people, 12.50%
Comtan: 2 people, 12.50%
Dexamethasone: 2 people, 12.50%

What are other side effects people have besides Appetite - decreased? *

Nausea (feeling of having an urge to vomit): 5 people, 31.25%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 4 people, 25.00%
Pseudomembranous Colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon): 4 people, 25.00%
Disease Progression: 4 people, 25.00%
Hypovolaemia (a decreased volume of circulating blood in the body): 4 people, 25.00%
Infection: 4 people, 25.00%
Dehydration (dryness resulting from the removal of water): 4 people, 25.00%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 25.00%
Pleural Effusion (water on the lungs): 4 people, 25.00%
Weight Increased: 4 people, 25.00%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 31.25%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 4 people, 25.00%
Constipation: 3 people, 18.75%
Osteoporosis (bones weak and more likely to break): 3 people, 18.75%
Insomnia (sleeplessness): 3 people, 18.75%
Stress And Anxiety: 2 people, 12.50%
Infection: 2 people, 12.50%
Alcoholic Liver Disease: 2 people, 12.50%
Diabetes: 2 people, 12.50%
Drug Effect Decreased: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Kanzo and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kanzo:

Kanzo (352 reports)

Browse all side effects of Kanzo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,524 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,592 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on licorice (the active ingredients of Kanzo) and Kanzo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.